BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 23003320)

  • 1. A comparison of human immunodeficiency virus, hepatitis C virus, hepatitis B virus, and human T-lymphotropic virus marker rates for directed versus volunteer blood donations to the American Red Cross during 2005 to 2010.
    Dorsey KA; Moritz ED; Steele WR; Eder AF; Stramer SL
    Transfusion; 2013 Jun; 53(6):1250-6. PubMed ID: 23003320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of selected viral infections among temporarily deferred donors who returned to donate blood: American Red Cross blood donor study.
    Zou S; Musavi F; Notari EP; Fujii KE; Dodd RY;
    Transfusion; 2005 Oct; 45(10):1593-600. PubMed ID: 16181210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of viral markers among first-time Arab blood donors in Kuwait.
    Ameen R; Sanad N; Al-Shemmari S; Siddique I; Chowdhury RI; Al-Hamdan S; Al-Bashir A
    Transfusion; 2005 Dec; 45(12):1973-80. PubMed ID: 16371052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in prevalence, incidence, and residual risk of major transfusion-transmissible viral infections in United Arab Emirates blood donors: impact of individual-donation nucleic acid testing, 2004 through 2009.
    Al Shaer L; AbdulRahman M; John TJ; AlHashimi A
    Transfusion; 2012 Nov; 52(11):2300-9. PubMed ID: 22691239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000.
    Chiavetta JA; Escobar M; Newman A; He Y; Driezen P; Deeks S; Hone DE; O'Brien SF; Sher G
    CMAJ; 2003 Oct; 169(8):767-73. PubMed ID: 14557314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
    Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
    Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.
    Hourfar MK; Jork C; Schottstedt V; Weber-Schehl M; Brixner V; Busch MP; Geusendam G; Gubbe K; Mahnhardt C; Mayr-Wohlfart U; Pichl L; Roth WK; Schmidt M; Seifried E; Wright DJ;
    Transfusion; 2008 Aug; 48(8):1558-66. PubMed ID: 18466173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence, incidence, and residual risk of major blood-borne infections among apheresis collections to the American Red Cross Blood Services, 2004 through 2008.
    Zou S; Musavi F; Notari EP; Stramer SL; Dodd RY
    Transfusion; 2010 Jul; 50(7):1487-94. PubMed ID: 20345571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current value of serologic test for syphilis as a surrogate marker for blood-borne viral infections among blood donors in the United States.
    Zou S; Notari EP; Fang CT; Stramer SL; Dodd RY
    Transfusion; 2009 Apr; 49(4):655-61. PubMed ID: 19170999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of additional blood screening tests in the Netherlands.
    Borkent-Raven BA; Janssen MP; van der Poel CL; Bonsel GJ; van Hout BA
    Transfusion; 2012 Mar; 52(3):478-88. PubMed ID: 21880046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative safety of first-time volunteer and replacement donors in West Africa.
    Allain JP; Sarkodie F; Asenso-Mensah K; Owusu-Ofori S
    Transfusion; 2010 Feb; 50(2):340-3. PubMed ID: 19843284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor testing and risk: current prevalence, incidence, and residual risk of transfusion-transmissible agents in US allogeneic donations.
    Zou S; Stramer SL; Dodd RY
    Transfus Med Rev; 2012 Apr; 26(2):119-28. PubMed ID: 21871776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. Retrovirus Epidemiology Donor Study (REDS).
    Glynn SA; Kleinman SH; Schreiber GB; Busch MP; Wright DJ; Smith JW; Nass CC; Williams AE
    JAMA; 2000 Jul; 284(2):229-35. PubMed ID: 10889598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services.
    O'Brien SF; Yi QL; Fan W; Scalia V; Kleinman SH; Vamvakas EC
    Transfusion; 2007 Feb; 47(2):316-25. PubMed ID: 17302779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of replacement blood donors to study the epidemiology of major blood-borne viruses in the general population of Maputo, Mozambique.
    Cunha L; Plouzeau C; Ingrand P; Gudo JP; Ingrand I; Mondlane J; Beauchant M; Agius G
    J Med Virol; 2007 Dec; 79(12):1832-40. PubMed ID: 17935167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does prevalence of transfusion-transmissible viral infection reflect corresponding incidence in United States blood donors?
    Wang B; Schreiber GB; Glynn SA; Kleinman S; Wright DJ; Murphy EL; Busch MP;
    Transfusion; 2005 Jul; 45(7):1089-96. PubMed ID: 15987352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probability of viremia with HBV, HCV, HIV, and HTLV among tissue donors in the United States.
    Zou S; Dodd RY; Stramer SL; Strong DM;
    N Engl J Med; 2004 Aug; 351(8):751-9. PubMed ID: 15317888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV, HCV, HBV and syphilis rate of positive donations among blood donations in Mali: lower rates among volunteer blood donors.
    Diarra A; Kouriba B; Baby M; Murphy E; Lefrere JJ
    Transfus Clin Biol; 2009; 16(5-6):444-7. PubMed ID: 19896404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
    Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
    Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study.
    Schreiber GB; Busch MP; Kleinman SH; Korelitz JJ
    N Engl J Med; 1996 Jun; 334(26):1685-90. PubMed ID: 8637512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.